ooking statements involve known and unknown
risks, uncertainties and other factors that could significantly impact
results or achievements expressed or implied by such forward-looking
statements. These factors include, but are not limited to, economic,
competitive, governmental, and technological factors affecting the
Company's operations, markets, products, services, and prices.
Consolidated Statements of Operations [unaudited]
(in thousands, except per share data)
Three Months Ended
July 31 July 31
2007 2006
Net sales $20,784 $19,294
Cost of products sold 16,521 16,166
Gross profit 4,263 3,128
Operating expenses 3,148 2,637
Operating earnings 1,115 491
Other income 3 18
Interest expense (110) (187)
Earnings before income taxes 1,008 322
Income tax expense 312 78
Earnings before minority interests 696 244
Minority interests in subsidiaries 22 111
Net earnings $674 $133
Net earnings per share
Basic $0.27 $0.05
Diluted $0.27 $0.05
Weighted average number of common
shares outstanding (in thousands)
Basic 2,502 2,492
Diluted 2,521 2,493
Condensed Consolidated Balance Sheets
(in thousands)
'/>"/>
SOURCE Kewaunee Scientific Corporation Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
UW-Madisons Beebe wins scientific award2.
Researchers say scientific reporting needs more perspective, less hype3.
Wisconsin stands at the center of scientific efforts to avert flu epidemics4.
Growth prompts new location for scientific instrument manufacturer5.
UW stem cell guru outlines scientific and political future6.
Wisconsin biotech sector featured in scientific magazine7.
Scientific Protein Laboratories Acquired by New York firm8.
GenTel Appoints Burke to its Scientific Advisory Board9.
Speaker announces business members of IT Task Force10.
Doyle announces technology tax credits for Berbee11.
Doyle announces new energy, global warming policies